also known as Candida sp identified in Stool by Organism specific culture
Identification of abnormal levels of specific yeast species in the stool is an important diagnostic step in therapeutic planning for the patient with chronic gastrointestinal and extra-gastrointestinal symptoms. Antimicrobial susceptibility testing to prescriptive and natural agents is also performed for appropriate fungal species at no additional charge. This provides useful clinical information to help plan an appropriate treatment protocol. This test can be added on to: GI Pathogen Profile Additional Biomarkers Available for add-on at additional cost: Bacteriology, aerobic Comp Clostridium Culture